GE Healthcare announces acquisition

GE Healthcare has announced the acquisition of SeqWright, a provider of nucleic acid sequencing and other genomic services.

This purchase complements Clarient, a unit of GE Healthcare, and provides a platform for Clarient to expand its clinical diagnostic offerings.

Pascale Witz, President and CEO of GE Healthcare, Medical Diagnostics, commented, “Combining the expertise and capabilities of the two companies will enable GE Healthcare to offer a substantially wider range of services to the biopharmaceutical, diagnostic and research industries and eventually to patients and health care providers.”

Fei Lu, President and CEO of SeqWright, said, “This partnership will put us in a position to apply the power of new direct detection technologies to clinical and companion diagnostics, potentially revolutionizing the way healthcare decisions are made.”

For more information please visit ref="http://www.gehealthcare.com">www.gehealthcare.com